Navigation Links
Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types

blems worldwide. In 2006, GSK Bio distributed more than 1.1 billion doses of vaccines to 169 countries in both the developed and the developing world - an average of 3 million doses a day. Of those vaccine doses, approximately 136 million were doses of combination pediatric vaccines which protect the world's children from up to six diseases in one vaccine.

CERVARIX is a trademark of the GlaxoSmithKline group of companies.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, the company cautions investors that any forward-looking statements or projections made by the company, including those made in this Announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect the Group's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2006.

    References

    1.  Paavonen, J., Jenkins, D., Bosch, X., et al. Efficacy of a human

        papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) AS04 vaccine:

        a phase III randomized, controlled trial in young women, Published in

        June issue of Lancet 2007.

    2.  Munoz N, Bosch FX, Castellsague X et al. Against which human

        papillomavirus types shall we vaccinate and screen? The international

        perspective. International Journal of Cancer, 2004; 111: 278-285.

    3.  Saslow et al. American Cancer Society Guideline for Human

        Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its

        Precursors. CA Cancer J Clin 2007;57;7-28.

    4.  Gall, S., et al. Sustained Efficacy up to 5.5 years in women

        vaccinated with an AS04 Adjuvanted HPV 16/18 L1 VLP Vaccine. Presented

        at AACR Medical Meeting. April 17, 2007.

    5.  Giannini SL, Hanon E, et al. Enhanced humoral and memory B 
'"/>




Page: 1 2 3 4 5 6 7 

Related medicine technology :

1. Largest National U.S. Healthcare Facility MRSA Study Reveals
Infection Rates Eight Times Greater Than Previous Estimates
2. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
3. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides
Sustained Immune Response in 100 Percent of Women up to 55 Years of
Age
4. New England Journal of Medicine Publishes New Data on Gardasil,
Mercks Cervical Cancer Vaccine
5. Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100
Percent Protection Against Precancerous Lesions Caused By
Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than
Five Years
6. Nventa Announces Presentation of Positive HspE7 Data from
NCI-Sponsored Clinical Trial in Cervical Dysplasia
7. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
8. Data Available From Erbitux Phase III Study in First-Line Treatment
of Advanced Lung Cancer
9. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin
Rashes Caused by Widely Used Cancer Drugs
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:12/14/2009)... Calif., Dec. 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... AZ-004 is an inhalation product candidate being developed for ... or bipolar disorder. The IND for Staccato ... 2005. ,, "AZ-004 has delivered a predictable and consistent ...
(Date:12/14/2009)... BEACH, Fla., Dec. 14 Perry Baromedical, ... years, announces the launch of the Sigma Elite, ... technology of the Sigma Elite is available on ... ) and has a Patent Pending. ,, The ... Data Capture Via Computerized System for Each ...
(Date:12/14/2009)... DENVER, Dec. 14 Corgenix Medical ... developer and marketer of diagnostic test kits, ... Massachusetts-based life sciences company, announced today a ... Galectin-3 diagnostic products in enzyme-linked immunosorbent assay ... BG Medicine is seeking regulatory clearance in ...
Breaking Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2CalciMedica Appoints Evelyn Graham to its Board of Directors 14445 1CalciMedica Appoints Evelyn Graham to its Board of Directors 14445 2Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 1Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 2Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 1Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 2
... research from a team led by Dr. Jean-Claude ... Canada.TOULOUSE, France and ANN ARBOR, Mich., Feb. 3 ... pharmaceutical company developing HDL-related compounds for the treatment ... it has in-licensed intellectual property supporting an investigational ...
... Proactive Pharmacy Care approach designed to help improve medication ... R.I., Feb. 3 /PRNewswire/ -- ... CVS ) found that nearly half of patients ... recommended drug therapies, significantly increasing their risk for subsequent ...
Other Medicine Technology:Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
(Date:12/14/2009)... Dr. Marc Sedwitz Heads up 900-Member Physician Staff , ... ... Hospital La Jolla have elected Marc Sedwitz, MD, as the new ... over as head of the 900-member physician team on Jan. 1, ... will serve as medical staff liaison to Scripps La Jolla’s administrative ...
(Date:12/14/2009)... Steve Pasierb, President ,, NEW YORK, Dec. ... Monitoring the Future study (MTF) -- the largest survey ... and 12th graders -- underscores that teens, intentional abuse ... be a cause for concern, with an alarming number ... and relatives. ,, Teen Abuse of ...
(Date:12/14/2009)... 14 The Hemophilia Federation of America ... issues involving the Teamsters Local 929 and the ... national blood system depends on skilled workers to ... is distilled into products such as clotting factor ... disease. ,, The Division of Blood Services ...
(Date:12/14/2009)... hadn,t spread, study finds , , MONDAY, Dec. 14 (HealthDay ... death in male colon cancer survivors, researchers report. , ... men who,d been treated for stage I, stage II ... (nonmetastatic cancer). Every two years, the men were sent ... disease diagnoses, as well as their physical activity. A ...
(Date:12/14/2009)... offer some protection, study finds, , , MONDAY, Dec. 14 ... can,t start their morning without a cup or two ... risk of developing type 2 diabetes. , That,s ... the more coffee you drink, the lower your risk ... a 7 percent reduction in the risk of diabetes, ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... Indian project meant to strengthen reading skills among neo-literates ... Google Foundation. // ,"This is not just ... It's Google!" exclaimed Ahmedabad-based academic Brij Kothari. ... of Management, Ahmedabad (IIM-A), has developed the SLS, an ...
... protest anomalies in the value added tax (VAT) implemented from ... to accept their demands. // ,"We have called ... demand and assured to bring an ordinance to ensure VAT ... Kumar Sinha, secretary of the Jharkhand Druggist and Chemist Association ...
... to a media report over a thousand chickens have died in ... saying only five birds have died and the death also has ... ,The birds have died in a poultry farm at Manari village ... owner Santosh Kumar Panda. ,The dead chickens were apparently ...
... that less antibiotic used in food animals leads to ... a policy of restricting antibiotic use in food-producing animals ... drug-resistant bacteria found in its citizens. ,The ... the leading causes of food borne illness in industrialized ...
... to a recent article in the April issue of Archives ... area are printing tanning advertisements in their newspapers. // Tanning ... the 23 schools. In all, there were about 40 tanning ... for periods of up to four months. ,The ...
... process by which a small protein acts directly within ... while simultaneously suppressing appetite. // This discovery could potentially ... new study by a team led by a Canadian ... acts directly within muscles to increase the body's metabolism ...
Other Medicine News:Health News:Google Supports Indian's Novel Literacy Drive 2Health News:Antibiotics Used In Food Animals Causes Antibiotic Resistance In People 2Health News:A Protein May Help In Weight Loss Treatment 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: